Alakananda Herbals Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.81 M
as on 19-12-2024
- Revenue 38.62%
(FY 2020)
- Profit 198.30%
(FY 2020)
- Ebitda 114.27%
(FY 2020)
- Net Worth 17.04%
(FY 2020)
- Total Assets 6.05%
(FY 2020)
About Alakananda Herbals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.81 M.
Divya Akella, Akella Sarma, and Kalaga Murty serve as directors at the Company.
- CIN/LLPIN
U24233TG2007PTC053603
- Company No.
053603
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Alakananda Herbals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akella Sarma  | Managing Director | 23-Nov-2011 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kalaga Murty | Director | 23-Nov-2011 | Current |
| Divya Akella | Director | 16-Apr-2007 | Current |
Financial Performance of Alakananda Herbals.
Alakananda Herbals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 38.62% increase. The company also saw a substantial improvement in profitability, with a 198.3% increase in profit. The company's net worth Soared by an impressive increase of 17.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alakananda Herbals?
In 2020, Alakananda Herbals had a promoter holding of 20.00% and a public holding of 80.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Kalaga Integrated Health Care Private LimitedActive 9 years 6 months
Kalaga Murty is a mutual person
- Paratpara Integrated Healthcare Private LimitedActive 5 years 6 months
Kalaga Murty is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 31 Mar 2022 | ₹0.81 M | Open |
How Many Employees Work at Alakananda Herbals?
Unlock and access historical data on people associated with Alakananda Herbals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alakananda Herbals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alakananda Herbals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
